4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0000899243-18-030797
SVP, Chief Development Officer gave up 11,928 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Tubridy Karen L · SVP, Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-12-12 | Shares withheld for taxes : show line 1 in the form | −11,928 | $8.94 | $106,636 | 30,229 | D |
Loading xslF345X03/doc4.xml…